100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
110671-78-814- Hydroxy Clarithromycin
● Under development
| Katalog-Nr.:: | VE008176 |
|---|---|
| CAS-Nr.:: | 110671-78-8 |
| Summenformel:: | C38H69NO14 |
| Molare Masse:: | 763.96 g/mol |
Zusätzliche Informationen zu CAS 110671-78-8
Parent drug
ClarithromycinIUPAC-Name
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-(((2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12, 13-dihydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-14-(1-hydroxyethyl)-7-methoxy-3, 5, 7, 9, 11, 13-hexamethyloxacyclotetradecane-2, 10-dioneSynonyme
N/ABeschreibung
14 Hydroxy Clarithromycin (CAS No: 110671-78-8) is a metabolite of clarithromycin. Clarithromycin is an acid-stable and orally taken macrolide antimicrobial drug and is structurally similar to erythromycin. It has a broad spectrum of antimicrobial activity and blocks an array of Gram-positive and Gram-negative organisms especially atypical pathogens and some anaerobes.References
Baumann, Michaela, et al. “Aquatic Toxicity of the Macrolide Antibiotic Clarithromycin and Its Metabolites.†Chemosphere, vol. 120, Feb. 2015, pp. 192–98, https://doi.org/10.1016/j.chemosphere.2014.05.089. Peters, David H., and Stephen P. Clissold. “Clarithromycin.†Drugs, vol. 44, no. 1, July 1992, pp. 117–64, https://doi.org/10.2165/00003495-199244010-00009.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Clarithromycin impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
Clarithromycin/ Erythromycin/ Roxithromycin
CAS No. 111321-02-9
Cat No. VL740012
